Discover 1,808 paid clinical trials in Richardson, Texas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,808
FeaturedActive & Responsive
Multicenter Study of Lumateperone for the Treatment of Bipolar Depression in Pediatric Patients
for
Bipolar Depression
Location: 35 recruiting locations
Sponsor: Intra-Cellular Therapies, Inc.
Sex: All
Age: 10 - 17
Code: NCT06372964
Phase3, Recruiting
FeaturedActive & Responsive
Effect of Amnio-Maxx on the Healing Rate of Chronic Diabetic Foot Ulcers.
for
Diabetic Foot Ulcer (DFU), Amnio-Maxx
Location: 8 recruiting locations
Sponsor: Royal Biologics
Sex: All
Age: 18+
Code: NCT07209475
Recruiting
Active & Responsive
Registry of AvanceĀ® Nerve Graft's Utilization and Recovery Outcomes Post Peripheral Nerve Reconstruction
LUNAR-2: TTFields With Pembrolizumab + Platinum-based Chemotherapy for Metastatic NSCLC
for
Metastatic Non-small Cell Lung Cancer
Location: 34 recruiting locations
Sponsor: NovoCure GmbH
Sex: All
Age: 18+
Code: NCT06216301
Phase3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active & Responsive
A Trial of the Efficacy and Safety of SEP-363856 in Acutely Psychotic Participants With Schizophrenia
for
Schizophrenia
Location: 20 recruiting locations
Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc.
Sex: All
Age: 18 - 65
Code: NCT06894212
Phase3, Recruiting
Active & Responsive
A Surveillance Study of Susceptibility to Baloxavir Marboxil in Pediatric Participants With Influenza and Transmission of Influenza to Household Contacts
for
Influenza
Location: 15 recruiting locations
Sponsor: Hoffmann-La Roche
Sex: All
Age: 0 - 11
Code: NCT06094010
Phase3, Recruiting
Active & Responsive
Collection of Blood From Healthy Patients, Patients With Benign Disease and Patients With Cancer
A Study to Evaluate the Efficacy and Safety of Adjunctive KarXT for the Treatment of Mania, With or Without Mixed Features, in Participants With Bipolar-I Disorder Taking Lithium, Valproate, or Lamotrigine
for
Mania, Bipolar Disorder
Location: 7 recruiting locations
Sponsor: Bristol-Myers Squibb
Sex: All
Age: 18 - 65
Code: NCT07140913
Phase3, Recruiting
Active & Responsive
Study Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Bipolar I Disorder